ARCHIVES

Research teams link response to Iressa to mutations in EGF receptor.

This article is from The Cancer Letter archive.

Vol. 30 No. 18 | April 30, 2004

Download PDF Visit The Full Archive

Related Articles

In Brief: AACR, ASCO to Sponsor Joint Symposium on Oncogenes; AACI Hosts Congressional Staff

February 15, 1985

FDA Invites Ad Hoc Consumer Reps To ODAC Meetings

February 17, 1995

Obituary: Joan Mauer, 65, Chief, NCI Clinical Trials Monitoring Branch

October 15, 2010

National Cancer Institute Lists Approved Clinical Trials

January 31, 2003

Single-Letter Mutation Found Responsible For Waldenstrom’s

December 30, 2011

Clinical Trials: NCI Puts State of Science Meetings on the Web

May 12, 2000